Status:
COMPLETED
A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI
Lead Sponsor:
NYU Langone Health
Conditions:
NSTEMI
Eligibility:
All Genders
75+ years
Phase:
NA
Brief Summary
This study will be a single-center, prospective, un-blinded, randomized controlled trial evaluating a decision aid tool for older patients considering left heart catheterization (LHC) as treatment for...
Detailed Description
A single-center, prospective, un-blinded, randomized controlled trial. Primary objective: To pilot a coronary revascularization decision aid in older adults with NSTEMI who are candidates for elective...
Eligibility Criteria
Inclusion
- Must be admitted to the hospital, and there must be clinical suspicion for type I NSTEMI
- Must be eligible for non-urgent revascularization
- Must have capacity to consent for the study based on the judgment of the study investigators
- Must speak English
Exclusion
- Does not meet all of the inclusion criteria listed above
- Has significant vision or hearing impairment that prohibits use of the decision aid
- Unable to read
- Has a clinical diagnosis of dementia and/or severe cognitive impairment documented in the electronic medical record
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04270630
Start Date
July 1 2020
End Date
December 1 2022
Last Update
July 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016